-
17th listing in 2024 on Euronext Growth Milan
-
37th listing on Euronext in 2024
-
The company raised €1.6 million
Borsa Italiana, part of the Euronext Group, today congratulates Predict on its listing on Euronext Growth Milan.
Predict is an innovative SME dedicated to the development of technologies in the healthcare sector and, primarily, in non-invasive in vivo diagnostics.
Predict’s listing is the 17th listing this year on Euronext Growth Milan, Borsa Italiana’s market for small and medium-sized companies, and it is Euronext’s 37th listing of this year.
In the placement phase, Predict raised €1.6 million, including the potential exercise of the over-allotment option (equal to €79.950).
Angelo Gigante, President and CEO of Predict, said:“We are very pleased to announce the listing of Predict in the Euronext Growth Milan market of Borsa Italiana. This milestone represents an important step in our growth path and positions us among the leading players in a rapidly expanding sector. With the listing, we open ourselves to investors and strategic partners who share with us the goal of continuing to invest in R&D in order to maintain a competitive advantage and offer increasingly advanced solutions. The listing represents the beginning of a new phase: we now look forward to the exciting opportunities that the breath analysis and digital healthcare markets hold in store for us.”
Caption: Isabella Cafagna and Loredana Amoruso, CEOs of Predict, Rocco Dichio, Board Director of Predict and Angelo Ceci, CFO of Predict, rang the bell during the market opening ceremony this morning to celebrate the company’s listing.
